Clinical Edge Journal Scan

Serum fatty acid profile tied to disease activity in early RA


 

Key clinical point: A serum lipid profile rich in long chain n-3 and n-6 polyunsaturated fatty acids (PUFA) was independently associated with a lower 6-month disease activity in a cohort of patients with early rheumatoid arthritis (RA).

Major finding: At 6 months, the odds of having a 28-joint Disease Activity Score of 5.1 was significantly lower in patients in higher tertiles of n-3 PUFA (odds ratio for tertile 3 vs 1 [ORt] 0.49; 95% CI 0.25-0.97) and n-6 PUFA (ORt 0.51; 95% CI 0.28-0.95), with the association being independent of baseline C-reactive protein levels.

Study details: This was a longitudinal cohort study including 669 patients with early RA.

Disclosures: This study was supported by Sorbonne Paris Nord University. The authors declared no conflicts of interest.

Source: Sigaux J et al. Serum fatty acid profiles are associated with disease activity in early rheumatoid arthritis: Results from the ESPOIR cohort. Nutrients. 2022;14(14):2947 (Jul 19). Doi: 10.3390/nu14142947

Recommended Reading

In RA, tofacitinib shows higher infection rate than TNF inhibitors
MDedge Rheumatology
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
MDedge Rheumatology
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
MDedge Rheumatology
Early methotrexate does not prevent progression to arthritis in arthralgia patients at risk for RA
MDedge Rheumatology
TNFi use during pregnancy in women with RA increases birth weight of offspring
MDedge Rheumatology
Risk for herpes zoster with first-line b/tsDMARD in seropositive RA in real world
MDedge Rheumatology
RA: Stopping bDMARD early in pregnancy increases risk for disease flare and preterm delivery
MDedge Rheumatology
Meta-analysis evaluates safety and efficacy of JAKi in RA
MDedge Rheumatology
Increased risk for dementia among patients with clinically active RA
MDedge Rheumatology
Presence of anti-SSA antibody reduces response to conventional RA treatment
MDedge Rheumatology